NCT06790277 Polyurethane Foam-Pink Pad (RCT) Use in OR
| NCT ID | NCT06790277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Abdullah Medical City |
| Condition | Cardiac Surgery Subjects |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-10 |
| Primary Completion | 2025-10-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-10 with a primary completion date of 2025-10-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
King Abdullah medical city has a cardiac center, and a lot of open-heart surgeries are performed there, and both polyurethane foam (pink Pad) and Mepilex dressing are applied to those patients. Therefore, the present study was designed to compare the effects of polyurethane foam (pink Pad) versus Mepilex dressing for prevention of pressure ulcer in operating room.
Eligibility Criteria
Inclusion Criteria: * Subjects ≥ 18. * Willing to participate. * Patients undergoing cardiac surgery. * Patient who is at risk for PU development as measured with Braden scale. * Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement. Exclusion Criteria: * Subjects under 17 * Not consenting to participate * Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients. * Patients who are unable to continue the study because of death or change in the care setting.
Contact & Investigator
Wedian O. Almowallad / Head of Clinical Trial Department, Master
✉ Almwlld.W@kamc.med.sa📞 012 5549999
Frequently Asked Questions
Who can join the NCT06790277 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Surgery Subjects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06790277 currently recruiting?
Yes, NCT06790277 is actively recruiting participants. Contact the research team at Almwlld.W@kamc.med.sa for enrollment information.
Where is the NCT06790277 trial being conducted?
This trial is being conducted at Mecca, Saudi Arabia.
Who is sponsoring the NCT06790277 clinical trial?
NCT06790277 is sponsored by King Abdullah Medical City. The trial plans to enroll 100 participants.